À propos de cet article
Publié en ligne: 14 oct. 2020
Pages: 69 - 76
DOI: https://doi.org/10.2478/inmed-2020-0126
Mots clés
© 2020 Paşc Priscilla et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Cardiometabolic syndrome (CMS), also known as metabolic syndrome X or insulin resistance syndrome is a cluster of metabolic abnormalities including central obesity associated with hyperglycemia, dyslipidemia or hypertension. Each component of CMS is individually associated with an increased risk of coronary events and has a different impact on outcomes and long-term mortality.